These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

289 related items for PubMed ID: 19530071

  • 1. Influence of various concentrations of terpene-4-ol enhancer and carbopol-934 mucoadhesive upon the in vitro ocular transport and the in vivo intraocular pressure lowering effects of dorzolamide ophthalmic formulations using albino rabbits.
    Afouna MI, Khedr A, Abdel-Naim AB, Al-Marzoqi A.
    J Pharm Sci; 2010 Jan; 99(1):119-27. PubMed ID: 19530071
    [Abstract] [Full Text] [Related]

  • 2. Designing of a pH-Triggered Carbopol®/HPMC In Situ Gel for Ocular Delivery of Dorzolamide HCl: In Vitro, In Vivo, and Ex Vivo Evaluation.
    Kouchak M, Mahmoodzadeh M, Farrahi F.
    AAPS PharmSciTech; 2019 Jun 03; 20(5):210. PubMed ID: 31161269
    [Abstract] [Full Text] [Related]

  • 3. Sustained ocular delivery of Dorzolamide-HCl via proniosomal gel formulation: in-vitro characterization, statistical optimization, and in-vivo pharmacodynamic evaluation in rabbits.
    Fouda NH, Abdelrehim RT, Hegazy DA, Habib BA.
    Drug Deliv; 2018 Nov 03; 25(1):1340-1349. PubMed ID: 29869516
    [Abstract] [Full Text] [Related]

  • 4. Enhanced ocular efficacy of topically-delivered dorzolamide with nanostructured mucoadhesive microparticles.
    Park CG, Kim YK, Kim SN, Lee SH, Huh BK, Park MA, Won H, Park KH, Choy YB.
    Int J Pharm; 2017 Apr 30; 522(1-2):66-73. PubMed ID: 28216468
    [Abstract] [Full Text] [Related]

  • 5. Topical drug delivery to the eye: dorzolamide.
    Loftsson T, Jansook P, Stefánsson E.
    Acta Ophthalmol; 2012 Nov 30; 90(7):603-8. PubMed ID: 22269010
    [Abstract] [Full Text] [Related]

  • 6. Effect of timolol, latanoprost, and dorzolamide on circadian IOP in glaucoma or ocular hypertension.
    Orzalesi N, Rossetti L, Invernizzi T, Bottoli A, Autelitano A.
    Invest Ophthalmol Vis Sci; 2000 Aug 30; 41(9):2566-73. PubMed ID: 10937568
    [Abstract] [Full Text] [Related]

  • 7. Ophthalmic formulations of the intraocular hypotensive melatonin agent 5-MCA-NAT.
    Andrés-Guerrero V, Alarma-Estrany P, Molina-Martínez IT, Peral A, Herrero-Vanrell R, Pintor J.
    Exp Eye Res; 2009 Mar 30; 88(3):504-11. PubMed ID: 19056382
    [Abstract] [Full Text] [Related]

  • 8. Pharmacodynamic equivalence study of two preparations of eye drops containing dorzolamide and timolol in healthy volunteers.
    Gatchev E, Petrov A, Kolev E, Hristova R, Demircheva I, Koytchev R, Richter W, Tegel F, Thyroff-Friesinger U.
    Arzneimittelforschung; 2011 Mar 30; 61(5):282-6. PubMed ID: 21755811
    [Abstract] [Full Text] [Related]

  • 9. Development of a poloxamer analogs/carbopol-based in situ gelling and mucoadhesive ophthalmic delivery system for puerarin.
    Qi H, Chen W, Huang C, Li L, Chen C, Li W, Wu C.
    Int J Pharm; 2007 Jun 07; 337(1-2):178-87. PubMed ID: 17254725
    [Abstract] [Full Text] [Related]

  • 10. Preparation of ophthalmic formulations containing cilostazol as an anti-glaucoma agent and improvement in its permeability through the rabbit cornea.
    Okamoto N, Ito Y, Nagai N, Murao T, Takiguchi Y, Kurimoto T, Mimura O.
    J Oleo Sci; 2010 Jun 07; 59(8):423-30. PubMed ID: 20625234
    [Abstract] [Full Text] [Related]

  • 11. New mucoadhesive chitosan film for ophthalmic drug delivery of timolol maleate: in vivo evaluation.
    Fulgêncio Gde O, Viana FA, Ribeiro RR, Yoshida MI, Faraco AG, Cunha-Júnior Ada S.
    J Ocul Pharmacol Ther; 2012 Aug 07; 28(4):350-8. PubMed ID: 22320419
    [Abstract] [Full Text] [Related]

  • 12. MK-927: a topically active ocular hypotensive carbonic anhydrase inhibitor.
    Sugrue MF, Gautheron P, Grove J, Mallorga P, Viader MP, Schwam H, Baldwin JJ, Christy ME, Ponticello GS.
    J Ocul Pharmacol; 1990 Aug 07; 6(1):9-22. PubMed ID: 2362161
    [Abstract] [Full Text] [Related]

  • 13. Improved pharmacodynamics of timolol maleate from a mucoadhesive niosomal ophthalmic drug delivery system.
    Aggarwal D, Kaur IP.
    Int J Pharm; 2005 Feb 16; 290(1-2):155-9. PubMed ID: 15664141
    [Abstract] [Full Text] [Related]

  • 14. Effect of PF-04217329 a prodrug of a selective prostaglandin EP(2) agonist on intraocular pressure in preclinical models of glaucoma.
    Prasanna G, Carreiro S, Anderson S, Gukasyan H, Sartnurak S, Younis H, Gale D, Xiang C, Wells P, Dinh D, Almaden C, Fortner J, Toris C, Niesman M, Lafontaine J, Krauss A.
    Exp Eye Res; 2011 Sep 16; 93(3):256-64. PubMed ID: 21376717
    [Abstract] [Full Text] [Related]

  • 15. Aqueous humor flow in normal human eyes treated with brimonidine and dorzolamide, alone and in combination.
    Tsukamoto H, Larsson LI.
    Arch Ophthalmol; 2004 Feb 16; 122(2):190-3. PubMed ID: 14769595
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Effects of pilocarpine in new ophthalmic formulations on intraocular pressure in rabbits with ocular hypertension].
    Xu Y, Chen Z, Song J.
    Zhonghua Yan Ke Za Zhi; 2002 Dec 16; 38(12):721-4. PubMed ID: 12654220
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Three-month, randomized, parallel-group comparison of brimonidine-timolol versus dorzolamide-timolol fixed-combination therapy.
    Nixon DR, Yan DB, Chartrand JP, Piemontesi RL, Simonyi S, Hollander DA.
    Curr Med Res Opin; 2009 Jul 16; 25(7):1645-53. PubMed ID: 19476406
    [Abstract] [Full Text] [Related]

  • 20. Effects of dorzolamide 2% added to timolol maleate 0.5% on intraocular pressure, retrobulbar blood flow, and the progression of visual field damage in patients with primary open-angle glaucoma: a single-center, 4-year, open-label study.
    Martínez A, Sánchez M.
    Clin Ther; 2008 Jun 16; 30(6):1120-34. PubMed ID: 18640468
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.